Clinical efficacy of sodium tanshinone IIA sulfonate in treatment of advanced schistosomiasis / 中国血吸虫病防治杂志
Chinese Journal of Schistosomiasis Control
; (6): 224-225, 2014.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-445681
Responsible library:
WPRO
ABSTRACT
Objective To evaluate the clinical efficacy of sodium tanshinone IIA sulfonate(STS)in the treatment of ad-vanced schistosomiasis. Methods Fifty cases with advanced schistosomiasis admitted to the Touzao Township Hospital of Dong-tai City during the period from November 2012 to November 2013 were treated with STS for 10 days,and the internal diameter of the portal vein,levels of ALT,AST,γ-GT,PIIIP,CIV,HA and LN were measured and compared before and after the adminis-tration of STS. Results The mean levels of all serological parameters except HA were within the normal range before STS treat-ment,while the highest positive rate was detected inγ-GT(26.0%)and HA(54.0%). Following the STS treatment,the mean lev-els of all parameters and the positive rates reduced,with the greatest reduction observed inγ-GT(36.7%)and HA(37.8%);how-ever,the mean HA level was still higher than the normal range. The mean internal diameter of the portal vein reduced from(10.5± 1.7)mm before the STS treatment to(9.8±1.3)mm after the STS administration,with a significant diffrtence(P<0.05). Conclu-sion STS appears effective in the treatment of advanced schistosomiasis.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
/
Neglected Diseases
Health problem:
Target 3.3: End transmission of communicable diseases
/
Neglected Diseases
/
Schistosomiasis
/
Zoonoses
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Schistosomiasis Control
Year:
2014
Document type:
Article